Home  >  Products  >  KCTD7 (potassium channel tetramerisation domain containing 7) Blocking Peptide (the N terminal of protein) (100ug)
KCTD7 (potassium channel tetramerisation domain containing 7) Blocking Peptide (the N terminal of protein) (100ug)

KCTD7 (potassium channel tetramerisation domain containing 7) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KCTD7 antibody (Catalogue #: ARP35422_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP35422
Size: 100 ug
Weight: 33kDa
Gene: 154881
Format: Lyophilized powder
Target: The KCTD gene family, including KCTD7, encode predicted proteins that contain N-terminal domain that is homologous to the T1 domain in voltage-gated potassium channels (see KCNA1; MIM 176260). KCTD7 displays a primary sequence and hydropathy profile indicating intracytoplasmic localization. EST database analysis showed that KCTD7 is expressed in human and mouse brain.The KCTD gene family, including KCTD7, encode predicted proteins that contain N-terminal domain that is homologous to the T1 domain in voltage-gated potassium channels (see KCNA1; MIM 176260). KCTD7 displays a primary sequence and hydropathy profile indicating intracytoplasmic localization. EST database analysis showed that KCTD7 is expressed in human and mouse brain (Van Bogaert et al., 2007 [PubMed 17455289]).[supplied by OMIM].
Alternative names: FLJ32069
See Full Product Listings >